Serum-free light chain elevation is associated with a shorter time to treatment in Waldenstrom's macroglobulinemia

被引：21

作者：

Itzykson, Raphael ^{[1
]}

Le Garff-Tavernier, Magali ^{[2
]}

Katsahian, Sandrine ^{[3
]}

Diemert, Marie-Claude ^{[2
]}

Musset, Lucile ^{[2
]}

Leblond, Veronique ^{[1
,4
]}

机构：

[1] Hop La Pitie Salpetriere, AP HP, Serv Hematol, F-75013 Paris, France

[2] Hop La Pitie Salpetriere, AP HP, Serv Immunochim, Paris, France

[3] Hop St Louis, AP HP, Dept Biostat & Informat Med, Paris, France

[4] Univ Paris 06, Paris, France

来源：

HAEMATOLOGICA | 2008年 / 93卷 / 05期

关键词：

Waldenstrom's macroglobulinemia; serum-free light chain; time to treatment; prognosis;

D O I：

10.3324/haematol.12107

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：793 / 794

页数：2

共 10 条

[1] Asymptomatic Waldenstrom's macroglobulinemia [J].

Alexanian, R ;

Weber, D ;

Delasalle, K ;

Cabanillas, F ;

Dimopoulos, M .

SEMINARS IN ONCOLOGY, 2003, 30 (02) :206-210

[2]

Bradwell AR, 2001, CLIN CHEM, V47, P673

[3] Waldenstrom macroglobulinaemia:: presenting features and outcome in a series with 217 cases [J].

García-Sanz, R ;

Montoto, S ;

Torrequebrada, A ;

de Coca, AG ;

Petit, J ;

Sureda, A ;

Rodríguez-García, JA ;

Massó, P ;

Pérez-Aliaga, A ;

Monteagudo, MD ;

Navarro, I ;

Moreno, G ;

Toledo, C ;

Alonso, A ;

Besses, C ;

Besalduch, J ;

Jarque, I ;

Salama, P ;

Rivas, JAH ;

Navarro, B ;

Bladé, J ;

Miguel, JFS .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (03) :575-582

[4] Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia [J].

Ghobrial, IM ;

Fonseca, R ;

Gertz, MA ;

Plevak, MF ;

Larson, DR ;

Therneau, TM ;

Wolf, RC ;

Hoffmann, RJ ;

Lust, JA ;

Witzig, TE ;

Lacy, MQ ;

Dispenzieri, A ;

Rajkumar, SV ;

Zeldenrust, SR ;

Greipp, PR ;

Kyle, RA .

BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 (02) :158-164

[5] Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia:: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia [J].

Kyle, RA ;

Treon, SP ;

Alexanian, R ;

Barlogie, B ;

Björkholm, M ;

Dhodapkar, M ;

Lister, TA ;

Merlini, G ;

Morel, P ;

Stone, M ;

Branagan, AR ;

Leblond, W .

SEMINARS IN ONCOLOGY, 2003, 30 (02) :116-120

[6] Serum free light chains for monitoring multiple myeloma [J].

Mead, GP ;

Carr-Smith, HD ;

Drayson, MT ;

Morgan, GJ ;

Child, JA ;

Bradwell, AR .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (03) :348-354

[7]

Morel P, 2000, BLOOD, V96, P852

[8]

Morel P, 2006, INT PROGNOSTIC SCORI, P127

[9] 6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis [J].

Ocio, E. M. ;

Schop, R. F. J. ;

Gonzalez, B. ;

Van Wier, S. A. ;

Hernandez-Rivas, J. M. ;

Gutierrez, N. C. ;

Garcia-Sanz, R. ;

Moro, M. J. ;

Aguilera, C. ;

Hernandez, J. ;

Xu, R. ;

Greipp, P. R. ;

Dispenzieri, A. ;

Jalal, S. M. ;

Lacy, M. Q. ;

Gonzalez-Paz, N. ;

Gertz, M. A. ;

San Miguel, J. F. ;

Fonseca, R. .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (01) :80-86

[10] Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia [J].

Owen, RG ;

Treon, SP ;

Al-Katib, A ;

Fonseca, R ;

Greipp, PR ;

McMaster, ML ;

Morra, E ;

Pangalis, GA ;

Miguel, JFS ;

Branagan, AR ;

Dimopoulos, MA .

SEMINARS IN ONCOLOGY, 2003, 30 (02) :110-115

← 1 →